Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

Andreas Josefsson

Researcher

Andreas Josefsson
Researcher
andreas.josefsson@urology.gu.se

Postal Address: Avd för Urologi vid Inst för Kliniska vetenskaper, 51345 Göteborg
Visiting Address: Bruna stråket 11b, vån 2, SU/Sahlgrenska , 41345 Göteborg


Department of Urology at Institute of Clinical Sciences (More Information)
Sahlgrenska Universitetssjukhuset
413 45 Göteborg
0313424145
Visiting Address: Bruna stråket 11b V 2 SU/Sahlgrenska , 413 45 Göteborg

Latest publications

Performance and inter-observer variability of prostate MRI (PI-RADS version 2) outside high-volume centres.
Kimia Kohestani, Jonas Wallström, Niclas Dehlfors, Ole Martin Sponga, Marianne Månsson et al.
Scandinavian journal of urology, Journal article 2019
Journal article

Marked response to cabazitaxel in prostate cancer xenografts expressing androgen receptor variant 7 and reversion of acquired resistance by anti-androgens
E. B. Ylitalo, E. Thysell, C. Thellenberg-Karlsson, M. Lundholm, A. Widmark et al.
Prostate, Journal article 2019
Journal article

Immunoreactivity for prostate specific antigen and Ki67 differentiates subgroups of prostate cancer related to outcome
P. Hammarsten, Andreas Josefsson, E. Thysell, M. Lundholm, C. Hägglöf et al.
Modern Pathology, Journal article 2019
Journal article

TMPRSS2-ERG Expression Predicts Prostate Cancer Survival and Associates with Stromal Biomarkers
C. Hagglof, P. Hammarsten, K. Stromvall, L. Egevad, Andreas Josefsson et al.
Plos One, Journal article 2014
Journal article

High density of S100A9 positive inflammatory cells in prostate cancer stroma is associated with poor outcome.
Viktor Tidehag, Peter Hammarsten, Lars Egevad, Torvald Granfors, Pär Stattin et al.
European journal of cancer (Oxford, England : 1990), Journal article 2014
Journal article

Tumour epithelial expression levels of endocannabinoid markers modulate the value of endoglin-positive vascular density as a prognostic marker in prostate cancer.
Christopher J Fowler, Andreas Josefsson, Lina Thors, Sui Chu Chung, Peter Hammarsten et al.
Biochimica et biophysica acta, Journal article 2013
Journal article

Nuclear Stat5a/b predicts early recurrence and prostate cancer-specific death in patients treated by radical prostatectomy.
Tuomas Mirtti, Benjamin E Leiby, Junaid Abdulghani, Elina Aaltonen, Miia Pavela et al.
Human pathology, Journal article 2013
Journal article

Showing 11 - 19 of 19

2013

2012

Low endoglin vascular density and Ki67 index in Gleason score 6 tumours may identify prostate cancer patients suitable for surveillance.
Andreas Josefsson, Pernilla Wikström, Lars Egevad, Torvald Granfors, Lars Karlberg et al.
Scandinavian journal of urology and nephrology, Journal article 2012
Journal article

Phospho-Akt immunoreactivity in prostate cancer: relationship to disease severity and outcome, Ki67 and phosphorylated EGFR expression.
Peter Hammarsten, Mariateresa Cipriano, Andreas Josefsson, Pär Stattin, Lars Egevad et al.
PloS one, Journal article 2012
Journal article

2011

LRIG1 and the liar paradox in prostate cancer: a study of the expression and clinical significance of LRIG1 in prostate cancer.
Marcus Thomasson, Baofeng Wang, Peter Hammarsten, Anna Dahlman, Jenny Liao Persson et al.
International journal of cancer. Journal international du cancer, Journal article 2011
Journal article

Prostate cancer increases hyaluronan in surrounding nonmalignant stroma, and this response is associated with tumor growth and an unfavorable outcome.
Andreas Josefsson, Hani Adamo, Peter Hammarsten, Torvald Granfors, Pär Stattin et al.
The American journal of pathology, Journal article 2011
Journal article

2010

Low levels of phosphorylated epidermal growth factor receptor in nonmalignant and malignant prostate tissue predict favorable outcome in prostate cancer patients.
Peter Hammarsten, Amar Karalija, Andreas Josefsson, Stina Häggström Rudolfsson, Pernilla Wikström et al.
Clinical cancer research : an official journal of the American Association for Cancer Research, Journal article 2010
Journal article

Stromal PDGFRbeta expression in prostate tumors and non-malignant prostate tissue predicts prostate cancer survival.
Christina Hägglöf, Peter Hammarsten, Andreas Josefsson, Pär Stattin, Janna Paulsson et al.
PloS one, Journal article 2010
Journal article

2009

A high cannabinoid CB(1) receptor immunoreactivity is associated with disease severity and outcome in prostate cancer.
Sui Chu Chung, Peter Hammarsten, Andreas Josefsson, Pär Stattin, Torvald Granfors et al.
European journal of cancer (Oxford, England : 1990), Journal article 2009
Journal article

2005

Tumor size, vascular density and proliferation as prognostic markers in GS 6 and GS 7 prostate tumors in patients with long follow-up and non-curative treatment.
Andreas Josefsson, Pernilla Wikström, Torvald Granfors, Lars Egevad, Lars Karlberg et al.
European urology, Journal article 2005
Journal article

Showing 11 - 19 of 19

Page Manager: Katarina Olinder Eriksson|Last update: 1/7/2014
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?